Every SEC Form 3/4/5 on record for this filer (CIK 1198325) — 8 issuers, 86 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | Director | 2017-09-19 → 2026-03-03 | 19 | −$42M |
| ALLK | Allakos Inc. | Director · lapsed | 2018-07-18 → 2023-05-30 | 13 | $1M |
| TYRA | Tyra Biosciences, Inc. | 10% owner · lapsed | 2021-09-14 → 2021-09-17 | 2 | — |
| ESPR | Esperion Therapeutics, Inc. | Director · lapsed | 2016-06-10 → 2021-05-28 | 8 | −$16M |
| STRO | SUTRO BIOPHARMA, INC. | Director · lapsed | 2018-09-26 → 2019-06-19 | 6 | — |
| VIVE | VIVEVE MEDICAL, INC. | Director · lapsed | 2016-08-24 → 2019-01-02 | 15 | $2M |
| VIVMF | VIVEVE MEDICAL, INC. | Director · lapsed | 2015-11-25 → 2016-06-20 | 4 | $2M |
| NEOT | Neothetics, Inc. | Filer · lapsed | 2015-12-17 → 2015-12-30 | 2 | −$762,136 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KRYS | 2026-02-27 | Sell | 9,430 | $275.45 | $3M | 75,666 |
| KRYS | 2026-02-27 | Sell | 2,373 | $276.17 | $655,351 | 73,293 |
| KRYS | 2026-02-26 | Sell | 5,103 | $275.28 | $1M | 87,734 |
| KRYS | 2026-02-26 | Sell | 2,638 | $276.32 | $728,932 | 85,096 |
| KRYS | 2026-02-25 | Sell | 700 | $275.00 | $192,500 | 92,837 |
| KRYS | 2026-02-24 | Sell | 3,963 | $268.97 | $1M | 743 |
| KRYS | 2026-02-24 | Sell | 6,671 | $268.04 | $2M | 4,706 |
| KRYS | 2026-02-24 | Sell | 11,673 | $266.97 | $3M | 11,377 |
| KRYS | 2026-02-24 | Sell | 8,986 | $266.18 | $2M | 23,050 |
| KRYS | 2026-02-24 | Sell | 3,557 | $265.08 | $942,890 | 32,036 |
4 of 8 issuers are covered and open a security page; the rest are on file here only.
